Pneumococcal infections and adult with risk factors;Infections à pneumocoque et populations adultes à risque

Medecine et Maladies Infectieuses

Volumn 42, Issue 10, 2012, Pages 517-524

  Chidiac, C ^a  

^a CROIX ROUSSE HOSPITAL   (France)

Author keywords

Invasive infection; Risk factor; S. pneumoniae; Vaccine

Indexed keywords

CORTICOSTEROID; PNEUMOCOCCUS VACCINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; ALCOHOL ABUSE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; ASTHMA; BACTERIUM IDENTIFICATION; CHRONIC HEPATITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ELDERLY CARE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEART DISEASE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; LIVER CIRRHOSIS; MORTALITY; OBESITY; PNEUMOCOCCAL INFECTION; RHEUMATIC DISEASE; RISK ASSESSMENT; SICKLE CELL ANEMIA; SPLEEN DISEASE; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ADULT; HUMANS; PNEUMOCOCCAL INFECTIONS; RISK FACTORS;

EID: 84868703314     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.04.003     Document Type: Article

References (68)

1. Musher D.M. Streptococcus pneumoniae. Mandell, Douglas, Bennet's principles and practice of infectious diseases 2010, Churchill Livingstone Elsevier, Philadelphia. 7th edition. G.L. Mandell, J.E. Bennet, R. Dolin (Eds.).
2. Fekin D.R., Schutat A., Kolczak M., Barrett N.L., Harrisson L.H., Lefkowitz L., et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000, 90:223-229.
3. Chanet V., Lesens O., Laurichesse H., Beytout J. Infections chez l'adulte asplénique et prévention. Med Mal Inf 2004, 34:493-498.
4. Bisharat N., Omari H., Lavi I., Raz R. Risk of infection and death among post-splenectomy patients. J Infect 2001, 43:182-186.
5. Poinsignon Y. Prévention des infections sévères chez les splénectomisés : expérience nantaise (CHU Hôtel-Dieu) 1986-1993 et revue de la littérature. Thèse médecine 1994 ; Nantes.
6. Evans D. Post-splenectomy sepsis ten years or more after operation. J Clin Path 1985, 38:309-311.
7. Holdsworth R.J., Irving A.D., Cuschieri A. Post-splenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991, 78:1031-1038.
8. Zarkowsky H.S., Gallagher D., Gill F.M., Cooperative study of sickle cell disease Bacteremia in sickle hemoglobinopathies. J Pediatr 1986, 109:579-585.
9. Wong W.Y., Overtuft G.D., Powars D.R. Infection caused by Streptococcus pneumoniae in children with sickle cell disease: epidemiology, immunologic mechanisms, prophylaxis and vaccination. Clin Infect Dis 1992, 14:1124-1136.
10. Lepage P.H., Dresse M.F., Forget P., Schmitz V., Hoyoux C. Infections et prophylaxies anti-infectieuses dans la dxpanocytose. Rev Med Liege 2004, 59:145-148.
11. Lionnet F, Stankovic K, Girot R. Drépanocytose de l'adulte. EMC (Elsevier Masson SAS, Paris), Hématologie, 13-006-D-16, 2009.
12. Ramos Rincon M.J., Cuenca Estrella M., Fernandez Guerrero M.L. Estudio retrospectivo y comparativo de la bacteriemia neumócica en pacientes con hepatopatía crónica. Ann Med Int 1996, 13:313-316.
13. Gransden W.R., Eykyn S.J., Phillips I. Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's hospital. Br Med J (Clin Res Ed) 1985, 290:505-508.
14. Kyaw M.H., Rose C.E., Fry A.M., Singleton J.A., Moore Z., Zell E.R., et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005, 192:377-386.
15. Bouza E., Pintado V., Rivera S., Blázquez R., Muñoz P., Cercenado E., et al. Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect 2005, 11:919-924.
16. McCashland T.M., Preheim L.C., Gentry-Nielsen M.J. Pneumococcal vaccine response in cirrhosis and liver transplantation. J Infect Dis 2000, 181:757-760.
17. Loulergue P., Pol S., Mallet V., Sogni P., Launay O., for the GEVACCIM Group Why actively promote vaccination in patients with cirrhosis?. J Clin Virol 2009, 46:206-209.
18. Smeeth L., Thomas S.L., Hall A.J., Hubbard R., Farrington P., VallanceP. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004, 351:2611-2618.
19. Lichtman J.H., Fathi A., Radford M.J., Lin Z., Loeser C.S., Krumholz H.M. Acute, severe noncardiac conditions in patients with acute myocardial infarction. Am J Med 2006, 119:843-850.
20. Musher D.M., Rueda A.M., Kaka A.S., Mapara S.M. The association between pneumococcal pneumonia and acute cardiac events. Clin Infec Dis 2007, 45:158-165.
21. Ramirez J., Aliberti S., Mirsaeidi M., Peyrani P., Filardo G., Amir A., et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008, 47:182-187.
22. Tseng H.F., Slezak J.M., Quinn V.P., Sy L.S., Van Den Eeden S.K., Jacobsen S.J. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA 2010, 303:1699-1706.
23. Geiss L.S., Thompson T.J. Are persons with diabetes more likely to die from pneumonia and influenza? [abstract]. Diabetes 1995, 44:124A.
24. Valdez R., Narayan V., Geiss L.S., Engelgau M.M. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-hispanic black and white US adults. Am J Public Health 1999, 89:1715-1721.
25. Thomsen R.W., Hundborg H.H., Lervang H.H., Johnsen S.P., Schønheyder H.C., Sørensen H.T. Risk of community-acquired pneumococcal bacteremia in patients with diabetes: a population-based case-control study. Diabetes Care 2004, 27:1143-1147.
26. Farr B.M., Woodhead M.A., Macfarlane J.T., et al. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. Respir Med 2000, 94:422-427.
27. Robinson K.A., Baughman W., Rothrock G., Barrett N.L., Pass M., Lexau C., et al. Epidemiology of Invasive Streptococcus pneumoniae infections in the United States, 1995-1998. Opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285:1729-1735.
28. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005, 294:2043-2051.
29. Ruiz M., Ewig S., Marcos M., et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Resp Crit Care Med 1999, 160:397-405.
30. Koivula I., Sten M., Makela P.H. Risk factors for pneumonia in the elderly. Am J Med 1994, 96:313-320.
31. Loeb M., McGeer A., McArthur M., Simor A.E. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999, 159:2058-2064.
32. Vergis E.N., Brennen C., Wagener M., Muder R.R. Pneumonia in longterm care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med 2001, 161:2378-2381.
33. Trifiro G., Gambassi G., Caputi A.P., Bagnardi V., Brea J., Sturkenboom M.C.J.M. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients. A nested case-control study. Ann Intern Med 2010, 152:418-425.
34. Chidiac C., Ader F. Pneumococcal vaccine in the elderly: a useful but forgotten vaccine. Aging Clin Exp Res 2009, 21:222-228.
35. Janoff E.N., Breiman R.F., Daley C.L., Hopewell P.C. Pneumococcal disease during HIV infection: epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992, 117:314-324.
36. Heffernan R.T., Barrett N.L., Gallagher K.M., et al. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. J Infect Dis 2005, 191:2038-2045.
37. Pastor P., Medley F., Murphy T.V. Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995. Clin Infect Dis 1998, 26:590-595.
38. Gilks C.F., Ojoo S.A., Ojoo J.C., et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1-infected female sex-workers in Nairobi, Kenya. Lancet 1996, 347:718-723.
39. French N., Nakiyingi J., Carpenter L.M., et al. 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000, 355:2106-2111.
40. Grau I., Pallares R., Tubau F., et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005, 165:1533-1540.
41. Scarborough M., Gordon S.B., Whitty C.J., et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007, 357:2441-2450.
42. Lesprit P., Pédrono G., Molina J.M., Goujarde C., Girard P.M., Sarrazinb N., et al. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults. AIDS 2007, 21:2425-2434.
43. Søgaard O.S., Lohse N., Harboe Z.B., Offersen R., Bukh A.R., Davis H.L., et al. Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial. Clin Infect Dis 2010, 51:42-50.
44. Sogaard O.S., Lohse N., Gerstoft J., et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis 2008, 47:1345-1353.
45. Murugan A.T., Sharma G. Obesity and respiratory diseases. Chro Respir Dis 2008, 5:233-242.
46. Baik I., Curhan G.C., Rimm E.B., Bendich A., Willett W.C., Fawzi W.W. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med 2000, 160:3082-3088.
47. Talbot T.R., Hartert T.V., Mitchel E., Halasa N.B., Arbogast P.G., Poehling K.A., et al. Asthma as a risk factor for invasive pneumococcal disease. New Engl J Med 2005, 352:2082-2090.
48. Lipsky B.A., Boyko E.J., Inui T.S., et al. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986, 146:2179-2185.
49. Nichol K.L., Baken L., Wuorenma J., Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999, 159:2437-2442.
50. Alfageme I., Vazquez R., Reyes N., Munoz J., Fernandez A., Hernandez M., et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 2005, 61:189-195.
51. Nuorti J.P., Butler J.C., Farley M.M., Harrison L.H., Mc Geer A., Kolczak M.S., et al. Cigarette smoking and invasive pneumococcal disease. New Engl J Med 2000, 342:681-689.
52. Atzeni F., Bendtzen K., Bobbio-Pallavicini F., Conti F., Cutolo M., Montecucco, et al. Infections and treatment of patients with rheumatic diseases. Clin Exp Rheumatol 2008, 26:S67-S73.
53. Estrach C., Moots R.J., Andrews S., Williams D., Sykes H.R., Dawson J.K. High incidence of pneumonia in patients on anti-TNF therapy. Rheumatology 2002, 41:93.
54. Kroesen S., Widmer A.F., Tyndall A., Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF alpha therapy. Rheumatology 2003, 42:617-621.
55. Ellerin T., Rubin R.H., Weinblatt M.E. Infections and anti-tumor necrosis factor alpha therapy. Arthritis Rheum 2003, 48:3013-3022.
56. Farmaki E., Kanakoudi-Tsakalidou F., Spoulou V., Trachana M., Pratsidou-Gertsi P., Tritsoni M., et al. The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis. Vaccine 2011, 28:5109-5113.
57. Kulkarni S., Powles R., Treleaven J., et al. Chronic graft versus host disease is associated with long term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 2000, 95:3683-3686.
58. Engelhard D., Cordonnier C., Shaw P.J., et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European bone marrow transplantation survey. Br J Haematol 2002, 117:444-450.
59. Winston D.J., Schiffman G., Wang D.C., et al. Pneumococcal infections after human bone marrow transplantation. Ann Intern Med 1979, 91:835-841.
60. Hammarstrom V., Pauksen K., Azinge J., Oberg G., Ljungman P. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction. Support Care Cancer 1993, 1:195-199.
61. Winston D.J., Ho W.G., Schiffman G., Champlin R.E., Feig S.A., Gale R.P. Pneumococcal vaccination of recipients of bone marrowtransplants. Arch Intern Med 1983, 143:1735-1737.
62. Avanzini M.A., Carra A.M., Maccario R., et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995, 15:137-144.
63. Cordonnier C., Labopin M., Chesnel V., Ribaud P., De La Camara R., Martino R., et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis 2009, 48:1392-1401.
64. Cordonnier C., Labopin M., Chesnel V., Ribaud P., Camara Rde L., Martino R., et al. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. Vaccine 2010, 28:2730-2734.
65. Watt J.P., O'Brien K.L., Benin A.L., McCoy S.I., Donaldson C.M., Reid R., et al. Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol 2007, 166:1080-1087.
66. Le Calendrier des vaccinations et les recommandations vaccinales 2011 selon l'avis du Haut Conseil de la santé publique. BEH no 10-11, 22 mars 2011. 101-155. http://www.invs.sante.fr/beh/2011/10_11/beh_10_11_2011.pdf.
67. ACIP prevention of pneumococcal disease - recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and mortality weekly report [recommendations and reports series], 1997; 46:RR-8.
68. Pebody R.G., Leino T., Nohynek H., Hellenbrand W., Salmaso S., Ruutu P. Pneumococcal vaccination policy in Europe. Euro Surveill 2005, 10:174-178.